Circulating microRNA profiles altered in mice after 28d exposure to perfluorooctanoic acid

Toxicology Letters

Volumn 224, Issue 1, 2014, Pages 24-31

  Yan, Shengmin ^a   Wang, Jianshe ^a   Zhang, Wei ^a   Dai, Jiayin ^a  

^a INSTITUTE OF ZOOLOGY   (China)

Author keywords

Biomarker; Circulating miRNAs; Hepatotoxicity; Perfluorononanoic acid

Indexed keywords

LET 7I 5P; MCROIRNA 28 5P; MICRORNA; MICRORNA 130A 3P; MICRORNA 191 5P; MICRORNA 192 5P; MICRORNA 194 5P; MICRORNA 200C 3P; MICRORNA 295 3P; MICRORNA 32 5P; MICRORNA 322 5P; MICRORNA 328 3P; MICRORNA 339 5P; MICRORNA 34A 5P; MICRORNA 363 3P; MICRORNA 466J; MICRORNA 503 5P; MICRORNA 532 3P; MICRORNA 598 3P; MICRORNA 652 3P; MICRORNA 669H 5P; MICRORNA 704; MICRORNA 879 5P; MICRORNA 96 5P; MICRORNA122 5P; PERFLUOROOCTANOIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EXPOSURE; LIVER INJURY; LIVER TOXICITY; LIVER TUMOR; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; UPREGULATION;

ANIMALS; CAPRYLATES; FLUOROCARBONS; LIVER; MALE; MICE; MICE, INBRED BALB C; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84887539888     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2013.10.017     Document Type: Article

References (67)

1. Almeida M.I., Nicoloso M.S., Zeng L., Ivan C., Spizzo R., Gafa R., Xiao L., Zhang X., Vannini I., Fanini F., Fabbri M., Lanza G., Reis R.M., Zweidler-McKay P.A., Calin G.A. Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cells. Gastroenterology 2012, 142:886-896. e889.
2. Aranha M.M., Santos D.M., Sola S., Steer C.J., Rodrigues C.M. miR-34a regulates mouse neural stem cell differentiation. PLoS One 2011, 6:e21396.
3. Bala S., Petrasek J., Mundkur S., Catalano D., Levin I., Ward J., Alao H., Kodys K., Szabo G. Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases. Hepatology 2012, 56:1946-1957.
4. Balakathiresan N., Bhomia M., Chandran R., Chavko M., McCarron R.M., Maheshwari R.K. MicroRNA let-7i is a promising serum biomarker for blast-induced traumatic brain injury. J.Neurotrauma 2012, 29:1379-1387.
5. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
6. Bernardo B.C., Gao X.M., Winbanks C.E., Boey E.J., Tham Y.K., Kiriazis H., Gregorevic P., Obad S., Kauppinen S., Du X.J., Lin R.C., McMullen J.R. Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:17615-17620.
7. Buckley L.A., Dorato M.A. High dose selection in general toxicity studies for drug development: a pharmaceutical industry perspective. Regul. Toxicol. Pharmacol. 2009, 54:301-307.
8. Chang J., Nicolas E., Marks D., Sander C., Lerro A., Buendia M.A., Xu C., Mason W.S., Moloshok T., Bort R., Zaret K.S., Taylor J.M. miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol. 2004, 1:106-113.
9. Clarke R., Ressom H.W., Wang A., Xuan J., Liu M.C., Gehan E.A., Wang Y. The properties of high-dimensional data spaces: implications for exploring gene and protein expression data. Nat. Rev. Cancer 2008, 8:37-49.
10. Cui L., Zhou Q.F., Liao C.Y., Fu J.J., Jiang G.B. Studies on the toxicological effects of PFOA and PFOS on rats using histological observation and chemical analysis. Arch. Environ. Contam. Toxicol. 2009, 56:338-349.
11. Decaprio A.P. Biomarkers: Coming of age for environmental health and risk assessment. Environ. Sci. Technol. 1997, 31:1837-1848.
12. Dettmer M., Vogetseder A., Durso M.B., Moch H., Komminoth P., Perren A., Nikiforov Y.E., Nikiforova M.N. MicroRNA expression array identifies novel diagnostic markers for conventional and oncocytic follicular thyroid carcinomas. J. Clin. Endocrinol. Metab. 2013, 98:E1-E7.
13. Duan Z., Choy E., Harmon D., Liu X., Susa M., Mankin H., Hornicek F. MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration. Mol. Cancer Ther. 2011, 10:1337-1345.
14. Etheridge A., Lee I., Hood L., Galas D., Wang K. Extracellular microRNA: a new source of biomarkers. Mutat. Res. 2011, 717:85-90.
15. Eulalio A., Mano M., Dal Ferro M., Zentilin L., Sinagra G., Zacchigna S., Giacca M. Functional screening identifies miRNAs inducing cardiac regeneration. Nature 2012, 492:376-381.
16. Fischer L., Hummel M., Korfel A., Lenze D., Joehrens K., Thiel E. Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas. Neuro Oncol. 2011, 13:1090-1098.
17. Fornari F., Milazzo M., Chieco P., Negrini M., Calin G.A., Grazi G.L., Pollutri D., Croce C.M., Bolondi L., Gramantieri L. MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res. 2010, 70:5184-5193.
18. Gallo V., Leonardi G., Genser B., Lopez-Espinosa M.J., Frisbee S.J., Karlsson L., Ducatman A.M., Fletcher T. Serum perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) concentrations and liver function biomarkers in a population with elevated PFOA exposure. Environ. Health Perspect. 2012, 120:655-660.
19. Gocek E., Wang X., Liu X., Liu C.G., Studzinski G.P. MicroRNA-32 upregulation by 1,25-dihydroxyvitamin D3 in human myeloid leukemia cells leads to Bim targeting and inhibition of AraC-induced apoptosis. Cancer Res. 2011, 71:6230-6239.
20. Hauser S., Wulfken L.M., Holdenrieder S., Moritz R., Ohlmann C.H., Jung V., Becker F., Herrmann E., Walgenbach-Brunagel G., von Ruecker A., Muller S.C., Ellinger J. Analysis of serum microRNAs (miR-26a-2z.ast;, miR-191, miR-337-3p and miR-378) as potential biomarkers in renal cell carcinoma. Cancer Epidemiol. 2012, 36:391-394.
21. He L., He X., Lim L.P., de Stanchina E., Xuan Z., Liang Y., Xue W., Zender L., Magnus J., Ridzon D., Jackson A.L., Linsley P.S., Chen C., Lowe S.W., Cleary M.A., Hannon G.J. A microRNA component of the p53 tumour suppressor network. Nature 2007, 447:1130-1134.
22. Hermeking H. The miR-34 family in cancer and apoptosis. Cell Death Differ. 2010, 17:193-199.
23. Hou J., Lin L., Zhou W., Wang Z., Ding G., Dong Q., Qin L., Wu X., Zheng Y., Yang Y., Tian W., Zhang Q., Wang C., Zhang Q., Zhuang S.-M., Zheng L., Liang A., Tao W., Cao X. Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 2011, 19:232-243.
24. Iorio M.V., Visone R., Di Leva G., Donati V., Petrocca F., Casalini P., Taccioli C., Volinia S., Liu C.G., Alder H., Calin G.A., Menard S., Croce C.M. MicroRNA signatures in human ovarian cancer. Cancer Res. 2007, 67:8699-8707.
25. John E., Wienecke-Baldacchino A., Liivrand M., Heinaniemi M., Carlberg C., Sinkkonen L. Dataset integration identifies transcriptional regulation of microRNA genes by PPARgamma in differentiating mouse 3T3-L1 adipocytes. Nucleic Acids Res. 2012, 40:4446-4460.
26. Kendziorski C., Irizarry R.A., Chen K.S., Haag J.D., Gould M.N. On the utility of pooling biological samples in microarray experiments. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:4252-4257.
27. Kerr T.A., Korenblat K.M., Davidson N.O. MicroRNAs and liver disease. Transl. Res. 2011, 157:241-252.
28. Klaunig J.E., Hocevar B.A., Kamendulis L.M. Mode of Action analysis of perfluorooctanoic acid (PFOA) tumorigenicity and Human Relevance. Reprod. Toxicol. 2012, 33:410-418.
29. Koufaris C., Wright J., Currie R.A., Gooderham N.J. Hepatic microRNA profiles offer predictive and mechanistic insights after exposure to genotoxic and epigenetic hepatocarcinogens. Toxicol. Sci. 2012, 128:532-543.
30. Ladeiro Y., Couchy G., Balabaud C., Bioulac-Sage P., Pelletier L., Rebouissou S., Zucman-Rossi J. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 2008, 47:1955-1963.
31. Lau C., Anitole K., Hodes C., Lai D., Pfahles-Hutchens A., Seed J. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol. Sci. 2007, 99:366-394.
32. Li T., Cao H., Zhuang J., Wan J., Guan M., Yu B., Li X., Zhang W. Identification of miR-130a, miR-27b and miR-210 as serum biomarkers for atherosclerosis obliterans. Clin. Chim. Acta 2011, 412:66-70.
33. Lin C.Y., Wen L.L., Lin L.Y., Wen T.W., Lien G.W., Chen C.Y., Hsu S.H., Chien K.L., Sung F.C., Chen P.C., Su T.C. Associations between levels of serum perfluorinated chemicals and adiponectin in a young hypertension cohort in Taiwan. Environ. Sci. Technol. 2011, 45:10691-10698.
34. Lin F., Li R., Pan Z.X., Zhou B., Yu de B., Wang X.G., Ma X.S., Han J., Shen M., Liu H.L. miR-26b promotes granulosa cell apoptosis by targeting ATM during follicular atresia in porcine ovary. PLoS ONE 2012, 7:e38640.
35. Liu N., Landreh M., Cao K., Abe M., Hendriks G.J., Kennerdell J.R., Zhu Y., Wang L.S., Bonini N.M. The microRNA miR-34 modulates ageing and neurodegeneration in Drosophila. Nature 2012, 482:519-523.
36. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
37. Luo Y., Wang C., Chen X., Zhong T., Cai X., Chen S., Shi Y., Hu J., Guan X., Xia Z., Wang J., Zen K., Zhang C.Y., Zhang C. Increased serum and urinary microRNAs in children with idiopathic nephrotic syndrome. Clin. Chem. 2013, 59:658-666.
38. Mishra R., Chhatbar C., Singh S.K. HIV-1 Tat C-mediated regulation of tumor necrosis factor receptor-associated factor-3 by microRNA 32 in human microglia. J. Neuroinflamm. 2012, 9:131.
39. Murakami Y., Toyoda H., Tanaka M., Kuroda M., Harada Y., Matsuda F., Tajima A., Kosaka N., Ochiya T., Shimotohno K. The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families. PLoS ONE 2011, 6:e16081.
40. Olsen G.W., Zobel L.R. Assessment of lipid, hepatic, and thyroid parameters with serum perfluorooctanoate (PFOA) concentrations in fluorochemical production workers. Int. Arch. Occup. Environ. Health 2007, 81:231-246.
41. Oskowitz A.Z., Lu J., Penfornis P., Ylostalo J., McBride J., Flemington E.K., Prockop D.J., Pochampally R. Human multipotent stromal cells from bone marrow and microRNA: regulation of differentiation and leukemia inhibitory factor expression. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:18372-18377.
42. Ouyang L., Liu P., Yang S., Ye S., Xu W., Liu X. A three-plasma miRNA signature serves as novel biomarkers for osteosarcoma. Med. Oncol. 2013, 30:340.
43. Pasquinelli A.E. MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat. Rev. Genet. 2012, 13:271-282.
44. Peters J.M., Gonzalez F.J. Why toxic equivalency factors are not suitable for perfluoroalkyl chemicals. Chem. Res. Toxicol. 2011, 24:1601-1609.
45. Rahbari R., Holloway A.K., He M., Khanafshar E., Clark O.H., Kebebew E. Identification of differentially expressed microRNA in parathyroid tumors. Ann. Surg. Oncol. 2011, 18:1158-1165.
46. Rottiers V., Naar A.M. MicroRNAs in metabolism and metabolic disorders. Nat. Rev. Mol. Cell Biol. 2012, 13:239-250.
47. Shi X., Yeung L.W., Lam P.K., Wu R.S., Zhou B. Protein profiles in zebrafish (Danio rerio) embryos exposed to perfluorooctane sulfonate. Toxicol. Sci. 2009, 110:334-340.
48. Shimono Y., Zabala M., Cho R.W., Lobo N., Dalerba P., Qian D., Diehn M., Liu H., Panula S.P., Chiao E., Dirbas F.M., Somlo G., Pera R.A., Lao K., Clarke M.F. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 2009, 138:592-603.
49. Son H.Y., Kim S.H., Shin H.I., Bae H.I., Yang J.H. Perfluorooctanoic acid-induced hepatic toxicity following 21-day oral exposure in mice. Arch. Toxicol. 2008, 82:239-246.
50. Sonkoly E., Pivarcsi A. MicroRNAs in inflammation and response to injuries induced by environmental pollution. Mutat. Res. 2011, 717:46-53.
51. Starkey Lewis P.J., Dear J., Platt V., Simpson K.J., Craig D.G., Antoine D.J., French N.S., Dhaun N., Webb D.J., Costello E.M., Neoptolemos J.P., Moggs J., Goldring C.E., Park B.K. Circulating microRNAs as potential markers of human drug-induced liver injury. Hepatology 2011, 54:1767-1776.
52. Steenland K., Fletcher T., Savitz D.A. Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA). Environ Health Perspect 2010, 118:1100-1108.
53. Sukata T., Sumida K., Kushida M., Ogata K., Miyata K., Yabushita S., Uwagawa S. Circulating microRNAs, possible indicators of progress of rat hepatocarcinogenesis from early stages. Toxicol. Lett. 2011, 200:46-52.
54. Tan F., Jin Y., Liu W., Quan X., Chen J., Liang Z. Global liver proteome analysis using iTRAQ labeling quantitative proteomic technology to reveal biomarkers in mice exposed to perfluorooctane sulfonate (PFOS). Environ. Sci. Technol. 2012, 46:12170-12177.
55. Trebicka J., Anadol E., Elfimova N., Strack I., Roggendorf M., Viazov S., Wedemeyer I., Drebber U., Rockstroh J., Sauerbruch T., Dienes H.P., Odenthal M. Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis. J. Hepatol. 2013, 58:234-239.
56. Tryndyak V.P., Latendresse J.R., Montgomery B., Ross S.A., Beland F.A., Rusyn I., Pogribny I.P. Plasma microRNAs are sensitive indicators of inter-strain differences in the severity of liver injury induced in mice by a choline- and folate-deficient diet. Toxicol. Appl. Pharmacol. 2012, 262:52-59.
57. Wang F., Liu W., Ma J., Yu M., Jin Y., Dai J. Prenatal and neonatal exposure to perfluorooctane sulfonic acid results in changes in miRNA expression profiles and synapse associated proteins in developing rat brains. Environ. Sci. Technol. 2012, 46:6822-6829.
58. Wang J., Zhang Y., Zhang W., Jin Y., Dai J. Association of perfluorooctanoic acid with HDL cholesterol and circulating miR-26b and miR-199-3p in workers of a fluorochemical plant and nearby residents. Environ. Sci. Technol. 2012, 46:9274-9281.
59. Wang K., Zhang S., Marzolf B., Troisch P., Brightman A., Hu Z., Hood L.E., Galas D.J. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:4402-4407.
60. Wang L.G., Gu J. Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis. Cancer Epidemiol. 2012, 36:e61-e67.
61. Wolf C.J., Schmid J.E., Lau C., Abbott B.D. Activation of mouse and human peroxisome proliferator-activated receptor-alpha (PPARalpha) by perfluoroalkyl acids (PFAAs): further investigation of C4-C12 compounds. Reprod. Toxicol. 2012, 33:546-551.
62. Wright G.W., Simon R.M. A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics 2003, 19:2448-2455.
63. Wu N., Zhao X., Liu M., Liu H., Yao W., Zhang Y., Cao S., Lin X. Role of microRNA-26b in glioma development and its mediated regulation on EphA2. PLoS ONE 2011, 6:e16264.
64. Zhang L., Li Y.Y., Zeng H.C., Wei J., Wan Y.J., Chen J., Xu S.Q. MicroRNA expression changes during zebrafish development induced by perfluorooctane sulfonate. J. Appl. Toxicol. 2011, 31:210-222.
65. Zhang S.D., Gant T.W. Effect of pooling samples on the efficiency of comparative studies using microarrays. Bioinformatics 2005, 21:4378-4383.
66. Zhang W., Zhang Y., Zhang H., Wang J., Cui R., Dai J. Sex differences in transcriptional expression of FABPs in zebrafish liver after chronic perfluorononanoic acid exposure. Environ. Sci. Technol. 2012, 46:5175-5182.
67. Zhang Y., Yang Z., Whitby R., Wang L. Regulation of miR-200c by nuclear receptors PPARalpha, LRH-1 and SHP. Biochem. Biophys. Res. Commun. 2011, 416:135-139.